1-7 of 7
Juan Pablo Alderuccio
Close
Sort by
Journal Articles

Transformation of Marginal Zone Lymphoma to Hodgkin Lymphoma

Kamilia N Moalem, Juan Pablo Alderuccio, Côme Bommier, Thomas H Habermann, Brian K Link, James R Cerhan, Jorge Antenor Florindez, Izidore S Lossos
Journal: Blood Advances
Blood Adv bloodadvances.2024013434.
https://doi.org/10.1182/bloodadvances.2024013434
Published: 2024
Journal Articles

Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US Population-based Analysis

Jorge Florindez, Dai Chihara, Isildinha Reis, Izidore S Lossos, Juan Pablo Alderuccio
Journal: Blood Advances
Blood Adv bloodadvances.2024013499.
https://doi.org/10.1182/bloodadvances.2024013499
Published: 2024
Includes: Supplemental data
Journal Articles

Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial

Clinical Trials & Observations
Mehdi Hamadani, Alexander Spira, Xiaolei Zhou, Laura Liao, Lei Chen, John Radford, Weiyun Ai, Melhem Solh, Kirit M. Ardeshna, Brian Hess, Paolo F. Caimi, Anastasios Stathis, Carmelo Carlo-Stella, Juan Pablo Alderuccio, Brad Kahl, Ying Wang, Yajuan Qin, Zhiying Cindy Xu, Pier Luigi Zinzani
Journal: Blood Advances
Blood Adv (2023) 8 (1): 93–98.
https://doi.org/10.1182/bloodadvances.2023010636
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma

Clinical Trials & Observations
Raphael E. Steiner, Steven R. Hwang, Arushi Khurana, Thomas M. Habermann, Narendranath Epperla, Kaitlin Annunzio, Pamela Blair Allen, Katelin Baird, Darina Paulino, Juan Pablo Alderuccio, Izidore S. Lossos, Kevin David, Andrew M. Evens, Karan Pandya, Steven M. Bair, Manali Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Ryan Lynch, Stephen Smith, Lei Feng, Mansoor Noorani, Sairah Ahmed, Ranjit Nair, Francisco Vega, Susan Wu, Penny Fang, Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Hun J. Lee
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7485–7493.
https://doi.org/10.1182/bloodadvances.2023010700
Published: 2023
Includes: Supplemental data
Journal Articles

Postibrutinib relapse outcomes for patients with marginal zone lymphoma

Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K. Moyo, Nishitha Reddy, Julia Sheets, David M. Weiner, Praveen Ramakrishnan Geethakumari, Malathi Kandarpa, Ximena Jordan Bruno, Colin Thomas, Michael C. Churnetski, Andrew Hsu, Luke Zurbriggen, Xiao-wei Cherie Tan, Kathryn Lindsey, Joseph Maakaron, Paolo F. Caimi, Pallawi Torka, Celeste Bello, Sabarish Ayyappan, Timothy S. Oh, Reem Karmali, Seo-Hyun Kim, Anna Kress, Shalin Kothari, Yazeed Sawalha, Beth Christian, Kevin A. David, Irl Brian Greenwell, Murali Janakiram, Vaishalee P. Kenkre, Adam J. Olszewski, Jonathon B. Cohen, Neil Palmisiano, Elvira Umyarova, Ryan A. Wilcox, Farrukh T. Awan, Juan Pablo Alderuccio, Stefan K. Barta, Natalie S. Grover, Nilanjan Ghosh, Nancy L. Bartlett, Alex F. Herrera, Geoffrey Shouse
Journal: Blood Advances
Blood Adv (2023) 7 (1): 88–91.
https://doi.org/10.1182/bloodadvances.2022008634
Published: 2023
Includes: Supplemental data
Journal Articles

An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma

Clinical Trials & Observations
Juan Pablo Alderuccio, Luca Arcaini, Marcus P. Watkins, Anne W. Beaven, Geoffrey Shouse, Narendranath Epperla, Michele Spina, Alexandra Stefanovic, Jose Sandoval-Sus, Pallawi Torka, Ash B. Alpert, Adam J. Olszewski, Seo-Hyun Kim, Brian Hess, Sameh Gaballa, Sabarish Ayyappan, Jorge J. Castillo, Lisa Argnani, Timothy J. Voorhees, Raya Saba, Sayan Mullick Chowdhury, Fernando Vargas, Isildinha M. Reis, Deukwoo Kwon, Jonathan S. Alexander, Wei Zhao, Dali Edwards, Peter Martin, Emanuele Cencini, Manali Kamdar, Brian K. Link, Constantine N. Logothetis, Alex F. Herrera, Jonathan W. Friedberg, Brad S. Kahl, Stefano Luminari, Pier Luigi Zinzani, Izidore S. Lossos
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2035–2044.
https://doi.org/10.1182/bloodadvances.2021006844
Published: 2022
Journal Articles

HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis

Clinical Trials & Observations
Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens, Graham P. Collins, Alexey V. Danilov, Mark Bower, Deepa Jagadeesh, Catherine Zhu, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Catherine Wei, Suchitra Sundaram, Nishitha Reddy, Alessia Dalla Pria, Christopher D’Angelo, Umar Farooq, David A. Bond, Stephanie Berg, Michael C. Churnetski, Amandeep Godara, Nadia Khan, Yun Kyong Choi, Shireen Kassam, Maryam Yazdy, Emma Rabinovich, Frank A. Post, Gaurav Varma, Reem Karmali, Madelyn Burkart, Peter Martin, Albert Ren, Ayushi Chauhan, Catherine Diefenbach, Allandria Straker-Edwards, Andreas Klein, Kristie A. Blum, Kirsten Marie Boughan, Agrima Mian, Bradley M. Haverkos, Victor M. Orellana-Noia, Vaishalee P. Kenkre, Adam Zayac, Seth M. Maliske, Narendranath Epperla, Paolo Caimi, Scott E. Smith, Manali Kamdar, Parameswaran Venugopal, Tatyana A. Feldman, Daniel Rector, Stephen D. Smith, Andrzej Stadnik, Craig A. Portell, Yong Lin, Seema Naik, Silvia Montoto, Izidore S. Lossos, Kate Cwynarski
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2852–2862.
https://doi.org/10.1182/bloodadvances.2021004458
Published: 2021
Includes: Supplemental data